IP Library Granted Patent US 7,452,563
Granted Patent B2
US 7,452,563 · App. 11/155,738 · Granted Nov 18, 2008

Compositions and methods for producing flavored seasonings that contain reduced quantities of common salt

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,452,563
App. No.
11/155,738
Granted
Nov 18, 2008
Kind
B2
Abstract

The present invention provides flavored seasoning compositions containing low-salt substitutes that reduce the quantity of common salt used to flavor foods. More specifically, the compositions contain (a) a flavored seasoning mixture comprising flavoring agents, and flow agents, bulking agents, binding agents and/or preservatives, and (b) a salt substitute containing potassium chloride and bitterness inhibitors taurine and 5′-adenosinic acid, 5′-inosinic acid and/or 5′-guanylic acid. Furthermore, the present invention provides foods containing these compositions, methods of using these compositions and methods for preparing them.

Claims (64)

1. A composition comprising (a) a seasoning mixture comprising a flavoring agent and (b) a salt substitute, wherein said salt substitute comprises potassium chloride, taurine or a physiologically acceptable salt thereof, and a 5′-nucleotide monophosphate, comprising 5′-adenosinic acid (AMP) or 5′-inosinic acid (IMP) or a physiologically acceptable salt thereof.

2. A composition according to claim 1 , wherein said 5′-nucleotide monophosphate comprises AMP or a physiologically acceptable salt thereof.

3. A composition according to claim 1 , wherein said 5′-nucleotide monophosphate comprises IMP or a physiologically acceptable salt thereof.

4. A composition according to claim 1 , wherein said 5′-nucleotide monophosphate comprises a combination of AMP and IMP, or physiologically acceptable salts thereof.

5. A composition according to claim 1 , wherein said 5′-nucleotide monophosphate comprises a combination of AMP, IMP and 5′-guanylic acid (GMP) or physiologically acceptable salts thereof.

6. A composition according to claim 5 , wherein the amount of said IMP or physiologically acceptable salt thereof is up to about 4% w/w of said salt substitute.

7. A composition according to claim 5 , wherein the amount of GMP or physiologically acceptable salt thereof is up to about 4% w/w of said salt substitute.

8. A composition according to claim 5 , wherein the amount of said taurine or physiologically acceptable salt thereof is between about 2% and about 15%, the amount of said AMP or physiologically acceptable -guanylic acid (GMP) or physiologically acceptable salts thereof.

9. A composition according to claim 5 , wherein the amount of said taurine or physiologically acceptable salt thereof is between about 6% and about 8%, the amount of said AMP or physiologically acceptable salt thereof is between about 3% and about 6%, the amount of said IMP or physiologically acceptable salt thereof is up to about 3% and the amount of said GMP or physiologically acceptable salt thereof is up to about 3%, w/w of said salt substitute.

10. A composition according to claim 5 , wherein the amount of said potassium chloride is about 86.95%, the amount of said taurine or physiologically acceptable salt thereof is about 7.25%, the amount of said AMP or physiologically acceptable salt thereof is about 3.86%, the amount of said IMP or physiologically acceptable salt thereof is about 0.97% and the amount of said GMP or physiologically acceptable salt thereof is about 0.97%, w/w of said salt substitute.

11. A method of reducing sodium intake and increasing potassium intake in the diet of an individual, comprising administering to said individual the composition of claim 10 .

12. A composition according to claim 1 , wherein said 5′-nucleotide monophosphate consists essentially of AMP, IMP, GMP, combinations thereof or physiologically acceptable salts thereof.

13. A composition according to claim 1 , wherein said seasoning mixture further comprises a flow agent, binding agent or preservative.

14. A composition according to claim 13 , wherein said flavoring agent is between about 60% and about 99%, said flow agent is up to about 2%, said binding agent is up to about 30%, and said salt substitute is between about 1% and about 5%, w/w of said composition.

15. A composition according to claim 14 , wherein said flavoring agent is about 86%, said flow agent is about 1%, said binding agent is about 10% and said salt substitute is about 3%, w/w of said composition.

16. A composition according to claim 1 , wherein said flavoring agent is selected from a group consisting of a cheese flavoring agent, a meaty flavoring agent, an alliaceous flavoring agent, a tangy flavoring agent, a spicy flavoring agent and combinations thereof.

17. A composition according to claim 1 , wherein said flavoring agent is a cheese flavoring agent selected from the group consisting of nacho, cheddar, white cheddar, blue, mozzarella, asiago, american, brick, brie, feta, italian, monterey jack, muenster, provolone, ricotta, romano, swiss, taco and parmesan.

18. A composition according to claim 1 , wherein said composition comprises a snack, sauce, corn, pasta or dog biscuit.

19. A composition according to claim 1 , wherein said composition comprises a pretzel, popcorn, pizza, cracker, curl, puff, doodle, a chip, wherein said chip is selected from the group consisting of potato, corn, and tortilla.

20. A composition according to claim 1 , wherein said salt substitute is between about 1% and about 5% w/w of said composition.

21. A composition according to claim 20 , wherein said salt substitute is about 3% w/w of said composition.

22. A composition according to claim 1 , wherein said flavoring agent is between about 80% and about 90% w/w of said composition.

23. A composition according to claim 22 , wherein said flavoring agent is about 86% w/w of said composition.

24. A composition according to claim 1 , wherein the amount of said potassium chloride is between about 80% and about 98% w/w of said salt substitute.

25. A composition according to claim 1 , wherein the amount of said taurine or physiologically acceptable salt thereof is between about 2% and about 15% w/w of said salt substitute.

26. A composition according to claim 1 , wherein the amount of said AMP or physiologically acceptable salt thereof is between about 1% and about 8% w/w of said salt substitute.

27. A method of reducing sodium intake and increasing potassium intake in the diet of an individual, comprising administering to said individual the composition of claim 1 .

28. A method of preparing the composition of claim 1 , by mixing said salt substitute with said seasoning mixture.

29. A method of preparing the composition of claim 1 , comprising adding to a food the seasoning mixture, or individual ingredients thereof, and the salt substitute, or individual ingredients thereof.

30. A composition comprising (a) a seasoning mixture comprising a cheese flavoring agent, a tangy flavoring agent, an alliaceous flavoring agent, a flow agent and a binding agent and (b) a salt substitute comprising potassium chloride, taurine, and a 5′-nucleotide monophosphate, comprising AMP, IMP, GMP, combinations thereof or physiologically acceptable salts thereof.

31. A composition according to claim 30 , wherein said cheese flavoring agent comprises an intense flavoring agent resulting from the enzymatic modification of a cheese.

32. A composition according to claim 31 , wherein said intense flavoring agent is derived from romano or blue cheese.

33. A composition according to claim 30 , wherein said cheese flavoring agent is between about 60% and about 90% w/w of said composition.

34. A composition according to claim 33 , wherein said cheese flavoring agent is between about 75% and about 85% w/w of said composition.

35. A composition according to claim 30 , wherein said tangy flavoring agent comprises citric acid.

36. A composition according to claim 30 , wherein said tangy flavoring agent is between about 1% and about 10% w/w of said composition.

37. A composition according to claim 36 , wherein said tangy flavoring agent is between about 3% and about 7% w/w of said composition.

38. A composition according to claim 30 , wherein said alliaceous flavoring agent comprises onion powder or garlic powder.

39. A composition according to claim 38 , wherein said onion powder is up to about 5% w/w of said composition.

40. A composition according to claim 38 , wherein said garlic powder is up to about 5% w/w of said composition.

41. A composition according to claim 38 , wherein the amount of said cheese flavoring agent is about 79.5%, the amount of said tangy flavoring agent is about 3.5%, the amount of said onion powder is about 2%, the amount of said garlic powder is about 1%, the amount of said flow agent is about 1%, and the amount of said binding agent is about 10%, and the amount of salt substitute is about 3%, w/w of said composition, wherein said potassium chloride is about 86.95%, said taurine or physiologically acceptable salt thereof is about 7.25%, said AMP or physiologically acceptable salt thereof is about 3.86%, said IMP or physiologically acceptable salt thereof is about 0.97% and said GMP or physiologically acceptable salt thereof is about 0.97%, w/w of said salt substitute.

42. A method of reducing sodium intake and increasing potassium intake in the diet of an individual, comprising administering to said individual the composition of claim 41 .

43. A method of preparing the composition of claim 41 , by mixing said salt substitute with said seasoning mixture.

44. A composition according to claim 30 , wherein said cheese flavoring agent is between about 60% and about 90%, said tangy flavoring agent is between about 1% and about 10% and said alliaceous flavoring agent is up to about 10%, w/w of said composition.

45. A composition according to claim 30 , wherein said cheese flavoring agent is between about 75% and about 85%, said tangy flavoring agent is between about 3% and about 7% and said alliaceous flavoring agent is up to about 10%, w/w of said composition.

46. A composition according to claim 45 , wherein said flow agent is about 1% and said binding agent is about 10%, w/w of said composition.

47. A composition according to claim 30 , wherein said cheese flavoring agent is about 79.5%, said tangy flavoring agent is about 3.5% and said alliaceous flavoring agent is about 3%, w/w of said composition.

48. A composition according to claim 30 , wherein said flow agent is up to about 2% w/w of said composition.

49. A composition according to claim 30 , wherein said binding agent is up to about 30% w/w of said composition.

50. A composition according to claim 30 , further comprising a bulking agent.

51. A composition according to claim 30 , further comprising a preservative.

52. A composition according to claim 30 , wherein said salt substitute is between about 1% and about 5% w/w of said composition.

53. A composition according to claim 30 , wherein said salt substitute is about 3% w/w of said composition.

54. A composition according to claim 30 , wherein the amount of said potassium chloride is between about 80% and about 98% w/w of said salt substitute.

55. A composition according to claim 30 , wherein the amount of said taurine or physiologically acceptable salt thereof is between about 2% and about 15% w/w of said salt substitute.

56. A composition according to claim 30 , wherein the amount of said AMP or physiologically acceptable salt thereof is between about 1% and about 8% w/w of said salt substitute.

57. A composition according to claim 30 , wherein the amount of said IMP or physiologically acceptable salt thereof is up to about 4% w/w of said salt substitute.

58. A composition according to claim 30 , wherein the amount of GMP or physiologically acceptable salt thereof is up to about 4% w/w of said salt substitute.

59. A composition according to claim 30 , wherein the amount of said taurine or physiologically acceptable salt thereof is between about 2% and about 15%, the amount of said AMP or physiologically acceptable salt thereof is between about 1% and about 8%, the amount of said IMP or physiologically acceptable salt thereof is up to about 4% and the amount of said GMP or physiologically acceptable salt thereof is up to about 4%, w/w of said salt substitute.

60. A composition according to claim 30 , wherein the amount of said taurine or physiologically acceptable salt thereof is between about 6% and about 8%, the amount of said AMP or physiologically acceptable salt thereof is between about 3% and about 6%, the amount of said IMP or physiologically acceptable salt thereof is up to about 3% and the amount of said GMP or physiologically acceptable salt thereof is up to about 3%, w/w of said salt substitute.

61. A composition according to claim 30 , wherein the amount of said potassium chloride is about 86.95%, the amount of said taurine or physiologically acceptable salt thereof is about 7.25%, the amount of said AMP or physiologically acceptable salt thereof is about 3.86%, the amount of said IMP of physiologically acceptable salt thereof is about 0.97% and the amount of said GMP of physiologically acceptable salt thereof is about 0.97%, w/w of said salt substitute.

62. A method of reducing sodium intake and increasing potassium intake in the diet of an individual, comprising administering to said individual the composition of claim 30 .

63. A method of preparing the composition of claim 30 , by mixing said salt substitute with said seasoning mixture.

64. A method of preparing the composition of claim 30 , comprising adding to a food the seasoning mixture, or individual ingredients thereof, and the salt substitute, or individual ingredients thereof.

Assignments (11)
RELEASE OF SECURITY INTEREST Recorded Jun 2, 2022
From: PROTERRA FINANCE LLC, AS COLLATERAL AGENT
To: S & P INGREDIENT DEVELOPMENT, LLC
Reel/Frame 060088/0345 →
SECURITY AGREEMENT Recorded May 27, 2022
From: S & P INGREDIENT DEVELOPMENT, LLC
To: BMO HARRIS BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 060204/0584 →
RELEASE OF SECURITY INTEREST Recorded May 4, 2021
From: COMERICA BANK
To: S & P INGREDIENT DEVELOPMENT, LLC
Reel/Frame 056129/0794 →
SECURITY INTEREST Recorded Apr 30, 2021
From: S & P INGREDIENT DEVELOPMENT, LLC
To: PROTERRA FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 056096/0081 →
RELEASE OF SECURITY INTEREST Recorded May 16, 2016
From: NJTC VENTURE FUND SBIC, LP
To: REDPOINT BIO CORPORATION F/K/A LINGUAGEN CORP.
Reel/Frame 038605/0935 →
SECURITY INTEREST Recorded Mar 17, 2016
From: S & P INGREDIENT DEVELOPMENT, LLC
To: COMERICA BANK
Reel/Frame 038135/0942 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE'S NAME PREVIOUSLY RECORDED ON REEL 030335 FRAME 0224. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jun 7, 2013
From: REDPOINT BIO CORPORATION
To: S & P INGREDIENT DEVELOPMENT, LLC
Reel/Frame 030574/0481 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 2, 2013
From: REDPOINT BIO CORPORATION
To: NUTEK FOOD SCIENCE
Reel/Frame 030335/0224 →
CHANGE OF NAME Recorded Mar 8, 2007
From: LINGUAGEN CORP.
To: REDPOINT BIO CORPORATION
Reel/Frame 018972/0759 →
SECURITY AGREEMENT Recorded Jun 15, 2006
From: LINGUAGEN CORP.
To: NJTC VENTURE FUND SBIC, L.P.
Reel/Frame 017794/0931 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 26, 2005
From: SALEMME, FRANCIS RAYMOND; BAKAL, ABRAHAM I.; BARNDT, RICHARD
To: LINGUAGEN CORPORATION
Reel/Frame 016689/0459 →